Sector pending / Health ServicesUpdated 2026-05-10 22:07 UTC

BCBA/CVSD stock hub

BCBA/CVSD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/CVSDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

160.9T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/CVSD

In the news

Latest news · BCBA/CVSD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.9

P25 n/aP50 n/aP75 n/a

Trailing P/E39.7

P25 n/aP50 n/aP75 n/a

ROE3.8

P25 n/aP50 n/aP75 n/a

ROIC6.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/CVSD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$253.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Health Services
Last refreshed	2026-05-10
Market cap	$160.9T
Price	$6.2
Price currency	USD
Rev Per Employee	2,159,409,726.27x
Sic	8000
Symbol	bcba/CVSD
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.52%
EV Earnings	62.67x
EV/EBIT	16.81x
EV/EBITDA	9.89x
EV/FCF	24.85x
EV/Sales	0.45x
FCF yield	6.35%
Forward P/E	11.86x
P/B ratio	1.5x
P/E ratio	39.72x
P/S ratio	0.29x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.67%
EBITDA Margin	3.8%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	$75T
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	$4.1T
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	$15.6M
ROA	2.67
Roa5y	3.25
ROCE	6.51
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.6
Assets	$349.5T
Cash	$16.3T
Current Assets	$104.6T
Current Liabilities	$120.9T
Debt	$108.2T
Debt EBITDA	$4.25
Debt Equity	$1.01
Debt FCF	$10.6
Equity	$107.3T
Interest Coverage	3.49
Liabilities	$242.2T
Long Term Assets	$244.8T
Long Term Liabilities	$121.4T
Net Cash	$-91.9T
Net Cash By Market Cap	$-57.13
Net Debt EBITDA	$4.32
Net Debt Equity	$0.86
Net Debt FCF	$9
Tangible Book Value	$-45.7T
Tangible Book Value Per Share	$-35,913

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	$-26.1T
Quick ratio	0.61
Working Capital	$-16T
Working Capital Turnover	$-40,964

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	$120
Dividend Years	2
Dividend Yield	1,941.55%
Ex Div Date	2026-04-23
Last Dividend	$38.79
Payout Frequency	Quarterly
Payout Ratio	116.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	5.32
All Time High	6.22
All Time High Change	-0.32%
All Time High Date	2026-05-08
All Time Low	4.73
All Time Low Change	31.08%
All Time Low Date	2025-09-15
ATR	0.18
Ch YTD	12.32
High	6.2
High52	6.22
High52 Date	2026-05-08
High52ch	0%
Low	6.14
Low52	4.73
Low52 Date	2026-03-30
Low52ch	31.08%
Ma50ch	16.59%
RSI	71.25
RSI Monthly	0
RSI Weekly	63.53
Sharpe ratio	1.05x
Sortino ratio	1.65
Total Return	1,940.48%
Tr YTD	13.82
Tr1m	17.29%
Tr1w	8.01%
Tr3m	15.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$15T
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,329,087%
Net Borrowing	-2,370,725,169,315
Shares Insiders	0.1%
Shares Institutions	89.95%
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Ratio	2.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$9.3T
Average Volume	498.1x
Bv Per Share	84,058.5
CAPEX	$-4.1T
Ch1m	16.32
Ch1w	8.01
Ch3m	14.82
Ch6m	17.2
Change	2.99%
Change From Open	0.98
Close	6.02
Days Gap	1.99
Depreciation Amortization	6,387,670,706,939
Dollar Volume	3,887.4
Earnings Date	2026-08-05
EBIT	$15T
EBITDA	$21.3T
EPS	$3,171
F Score	6
FCF	$10.2T
FCF EV Yield	4.02x
Financing CF	-6,805,336,486,200
Fiscal Year End	December
Founded	1,963
Goodwill	119,554,481,429,326
Graham Number	3.80963
Graham Upside	-38.55
Income Tax	$765.4B
Investing CF	-8,265,596,467,100
Is Primary Listing	0
Last Report Date	2026-03-31
Lynch Fair Value	$0.78
Lynch Upside	-87.41
Ma150	5.34
Ma150ch	16.17%
Ma20	5.55
Ma20ch	11.75%
Net CF	-797,133,404,900
Next Earnings Date	2026-08-05
Open	6.14
P FCF Ratio	15.75
P OCF Ratio	11.27
Payment Date	2026-05-04
Position In Range	100
Ppne	38,851,919,618,426
Price Date	2026-05-08
Price EBITDA	$7.56
Relative Volume	1.38x
Revenue	560,366,823,966,599.94x
SBC By Revenue	0.17x
Share Based Comp	932,521,747,500
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr6m	18.77%
Volume	627
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/CVSD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1941.6%

$120 annual per share

Payout ratio

+116.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+1940.5%

Next ex-dividend date: 2026-04-23

Ownership

Who owns BCBA/CVSD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/CVSD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.3

Above 70: short-term overbought

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/CVSD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/CVSD stock rating?

bcba/CVSD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/CVSD analysis?

The full report lives at /stocks/bcba/CVSD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/CVSD?

The latest report frames bcba/CVSD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/CVSD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.